Anita Jackson, MD
Adult Medicine · Temecula, CANPI 1063519486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,646 and has fallen 63.9% since, to $594 in 2025. Among adult medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$697
- AbbVie$642
- Amgen$547
- Novo Nordisk$524
- Kowa Pharmaceuticals America, Inc.$483
- Amarin Pharma, Inc.$450
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $697 |
| AbbVie(2 entities) | 37 | $642 |
| Amgen(2 entities) | 24 | $547 |
| Novo Nordisk | 26 | $524 |
| Kowa Pharmaceuticals America, Inc. | 28 | $483 |
| Amarin Pharma, Inc. | 31 | $450 |
| GSK | 15 | $342 |
| Lilly USA, LLC | 15 | $324 |
| Abbott | 9 | $185 |
| Boehringer Ingelheim | 10 | $182 |
| Merck | 9 | $169 |
| Esperion Therapeutics, Inc. | 4 | $168 |
| Eisai Inc. | 11 | $167 |
| Johnson & Johnson | 8 | $166 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $138 |
| Bayer | 6 | $122 |
| Novartis | 6 | $101 |
| Pfizer | 4 | $89 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Biohaven Pharmaceuticals, Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Viiv Healthcare Company | 2 | $39 |
| Medtronic | 1 | $35 |
| Vertiflex, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Halozyme Inc | 1 | $21 |
| Mylan Specialty L.p. | 1 | $21 |
| Edwards Lifesciences | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Avion Pharmaceuticals | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,955 in reported general payments places this provider in the 90th percentile of 221 adult medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 56 | $66,349 |
| OzempicSemaglutide | 51 | $61,331 |
| FarxigaDapagliflozin Propanediol | 48 | $52,289 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 72 | $51,148 |
| JanuviaSitagliptin Phosphate | 34 | $36,215 |
| VascepaIcosapent Ethyl | 58 | $35,175 |
| EntrestoSacubitril/Valsartan | 34 | $26,575 |
| LinzessLinaclotide | 35 | $26,305 |
| OxycontinOxycodone Hcl | 21 | $26,013 |
| XareltoRivaroxaban | 29 | $24,970 |
| TrulicityDulaglutide | 19 | $23,275 |
| MyrbetriqMirabegron | 23 | $22,220 |
| ProliaDenosumab | 12 | $19,881 |
| TradjentaLinagliptin | 24 | $12,879 |
| Xigduo XrDapaglifloz Propaned/Metformin | 17 | $11,056 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $89 | $66,34956 claims |
| Novo NordiskOzempic | $524 | $61,33151 claims |
| AstraZenecaFarxiga | $697 | $52,28948 claims |
| GSKTrelegy Ellipta | $342 | $51,14872 claims |
| MerckJanuvia | $169 | $36,21534 claims |
| AbbVieLinzess, Synthroid | $642 | $30,24473 claims |
| NovartisEntresto | $101 | $26,57534 claims |
| Johnson & JohnsonXarelto | $166 | $24,97029 claims |
| Lilly USA, LLCTrulicity | $324 | $23,27519 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $22,22023 claims |
| AmgenProlia | $547 | $19,88112 claims |
| Boehringer IngelheimTradjenta, Stiolto Respimat | $182 | $18,54235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 221 adult medicine providers in California.
Other adult medicine in Temecula
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
- Sofia VaismanWoodland Hills$13K
- Janja ViltuznikOrange$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.